Injectable codeine is readily available for subcutaneous or intramuscular injection only; intravenous injection is contraindicated, as this may lead to nonimmune mast-cell degranulation and ensuing anaphylactoid response. Codeine suppositories will also be marketed in a few countries. In Eire, new polices came into effect on one August 2010[90] concerning codeine, https://codeingil.com/